Suppression of MRPL23 induces cellular senescence in hepatocellular carcinoma by targeting HMGB1
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer and remains a global health challenge. The biological process of HCC is very complex, involving the imbalance of tumor suppressor genes and oncogenes, abnormal activation of molecular signaling pathways, and the differen...
Saved in:
| Main Authors: | Ya-Bin Huang, Shi-meng Xu, Min Li, Jin Chen, Cui-Hua Lu, Qing-qing Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02885-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High expression of MRPL52 can be used as a prognostic marker of hepatocellular carcinoma and is related to immune infiltration
by: Nan HUANG, et al.
Published: (2021-12-01) -
Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker
by: Wenya Xing, et al.
Published: (2025-01-01) -
Targeting liver cancer stem cells: the prognostic significance of MRPL17 in immunotherapy response
by: Jingjing Shao, et al.
Published: (2024-12-01) -
Astragaloside IV represses hepatocellular carcinoma progression by modulating HMGB1-ferroptosis axis
by: Xingyang Zhao, et al.
Published: (2025-08-01) -
Identification of CCNB1 as a biomarker for cellular senescence in hepatocellular carcinoma: a bioinformatics and experimental validation study
by: Zhilan Zhang, et al.
Published: (2025-03-01)